Amdocs Limited Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2025: USD -793.51 M

Amdocs Limited Net Cash Used Provided By Financing Activities is USD -793.51 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.05% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Amdocs Limited Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -748.23 M, a 35.89% change year over year.
  • Amdocs Limited Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -550.63 M, a -27.34% change year over year.
  • Amdocs Limited Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -757.80 M, a 174.51% change year over year.
  • Amdocs Limited Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -276.06 M, a 170.69% change year over year.
Key Data
Date Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid Common Stock Issued